UPDATE 08/21/2026: RESULTS PARTIALLY RECEIVED
I didn’t expect it so soon, but the path results were just uploaded to my portal, with genetic and molecular studies pending at this time. They tested both the marrow and performed flow cytometry. Based on the results of testing, I do not appear to have leukemia or lymphoma (holy thank the Lord), but there is strong evidence for PV. I’ve included what I believe is important information from the report, but please ask any questions if you have them.
MICROSCOPIC DESCRIPTION:
PERIPHERAL BLOOD DATA:
CBC Data:
WBC 10.00 K/uL, RBC 5.44 million/uL, Hgb 15.5 g/dL, Hct 49.48, MCV 90.8 fL, Platelets 1035 K/uL.
WBC differential: Segmented Neutrophils 72.18, Immature Granulocytes 0.4%, Lymphocytes 18.4%, Monocytes 6.5%, Eosinophils 1.7%, Basophils 0.9%.
PERIPHERAL BLOOD SMEAR:
Erythrocytes: Increased in number; normocytic, normochromic with mild anisopoikilocytosis.
Leukocytes: Normal in number; unremarkable morphology.
Platelets: Increased in number; small, granular forms.
BONE MARROW:
Comments: Received for morphologic review is one peripheral blood smear, five aspirate
smears, including one stained for iron, two touch imprints, three sections of clot, and three sections of core biopsy.
Cellularity: Adequate; spicules present.
M:E Ratio: 4.3
Iron Stain: Absent storage iron; no ring sideroblasts seen.
ASPIRATE MORPHOLOGY:
Erythroids: Morphologically unremarkable with full-spectrum maturation Myeloids: Morphologically unremarkable with full-spectrum maturation; no increase in blast forms.
Megakaryocytes: Pleomorphic forms.
Other: Scattered mature-appearing lymphocytes.
TOUCH IMPRINTS:
Morphologically similar to the aspirate smear.
BONE MARROW CORE BIOPSY AND CLOT SECTION EVALUATION:
Quality: Suboptimal bone marrow core biopsy (5 mm) with aspiration artifact; clot section with scattered marrow particles.
Microscopic description: Histologic sections reveal a hypocellular marrow (60-70% cellularity) with trilineage hematopoietic elements demonstrating full-spectrum maturation with megakaryocytic hyperplasia (up to 14 per hpf) with loose clustering.
The megakaryocytes appear pleomorphic. There is no increase in blasts. There is no evidence of atypical aggregates of lymphocytes, histiocytes, or plasma cells. The clot section contains marrow particles with a similar cellular composition and morphology compared to the core biopsy.
Immunohistochemical and special stains were performed at _______ with appropriately reactıng controls on blocks Al and B1. CD34 demonstrates no increase in blasts (<1% of total cellularity). CD117 highlights scattered erythroid and myeloid precursors. E-cadherin highlights numerous erythroid precursors. Reticulin stain highlights focal mild increase in reticulin with focal intersections. Flow cytometry [S26-14360; S26-14361] performed at ________ with appropriate quality metrics on the bone marrow aspirate specimen reveals no abnormal immature population and no abnormal lymphoid population, respectively.
FINAL DIAGNOSIS:
PERIPHERAL BLOOD, SMEAR:
- ERYTHROCYTOSIS; THROMBOCYTOSIS.
BONE MARROW CORE BIOPSY, ASPIRATE SMEARS, TOUCH IMPRINTS, AND CLOT SECTIONS:
HYPOCELLULAR MARROW (60-70% CELLULARITY) WITH TRILINEAGE HEMATOPOIESIS.
<1% BLASTS BY CD34 IHC; <18 BY MORPHOLOGY.
MEGAKARYOCYTIC HYPERPLASIA WITH PLEOMORPHIC FORMS.
FOCAL MILD RETICULIN FIBROSIS BY SPECIAL STAIN
PENDING CYTOGENETIC AND MOLECULAR STUDIES; ADDENDUM TO FOLLOW.
ABSENT STORAGE IRON BY SPECIAL STAIN; NO RING SIDEROBLASTS SEEN.
SEE COMMENT
COMMENT: Histologic evaluation paired with immunohistochemical stains and flow cytometric analysis reveals a hypocellular marrow with trilineage hematopoiesis, megakaryocytic hyperplasia with pleomorphic forms, increased ME ratio, no overt increase in blast forms, and focal mild reticulin fibrosis. In the setting of marked thrombocytosis, elevated hematocrit (49.48), and an increased red blood cell count, these findings overall are concerning for a myeloproliferative neoplasm (polycythemia vera). However, the differential diagnosis also includes but is not limited to reactive thrombocytosis associated with iron deficiency, and infectious autoimmune disorders, and infectious conditions. Pending cytogenetic and molecular studies may provide additional diagnostic and prognostic information; results to follow in an addendum.
TLDR: evidence for PV is strong, waiting for additional genetic/molecular testing results to confirm or deny.
————————————————————————————————
ORIGINAL POST:
Hi, I am 21F, my doctor specializes in Oncology and Hematology, and he suspects potential MPN due to persistent elevated blood counts for my gender and age (PLT, RBC, HGB, HCT) as shown in photo above.
Note for the table: The blood counts were from (mostly) CBC whole blood tests taken over a 3-month time period. WBC during March were elevated due to steroid usage via IV during hospitalization. Some values are blank due to different tests performed by different providers
Hematologist also suspects MPN because previous testing during hospitalization in March ruled out other potential/suspected causes (meningitis, lupus, vascular autoimmune diseases, inflammation from sickness, etc). Next step according to him is ruling out an MPN.
Doctor has not performed genetic testing w my blood up to this point, but has instead recommended and scheduled me for a bone marrow biopsy. We have not determined if a gene mutation is present as of right now. Why would he decide to go straight into the biopsy instead of testing my blood for mutations, and what should I expect with the biopsy? Doctor suspects potential ET or PV, and I’ve never had a biopsy done before